Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia

Bajpai SK, Cambron-Mellott MJ, Will O, Poon JL, Wang Q, Mitchell BD, Peck EY, Babrowicz J, Raibulet NK, Child CJ, Beusterien K

Diabetes, Metabolic Syndrome and Obesity 2022, 15:3601-3615

Published Date: 21 November 2022